JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB78318

Anti-c-Myc (phospho S62) antibody [33A12E10]

Be the first to review this product! Submit a review

|

(34 Publications)

Mouse Monoclonal C-Myc/MYC phospho S62 antibody. Suitable for IHC-P, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 34 publications. Immunogen corresponding to Synthetic Peptide within Human MYC phospho S62.

View Alternative Names

BHLHE39, MYC, Myc proto-oncogene protein, Class E basic helix-loop-helix protein 39, Proto-oncogene c-Myc, Transcription factor p64, bHLHe39

5 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-c-Myc (phospho S62) antibody [33A12E10] (AB78318)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-c-Myc (phospho S62) antibody [33A12E10] (AB78318)

IHC image of ab78318 staining in human normal cervical carcinoma formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab78318, 1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Immunocytochemistry/ Immunofluorescence - Anti-c-Myc (phospho S62) antibody [33A12E10] (AB78318)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-c-Myc (phospho S62) antibody [33A12E10] (AB78318)

ab78318 staining (green) and DAPH staining (blue) of c-Myc (phospho S62) in HeLa cells by ICC/IF.

Immunocytochemistry/ Immunofluorescence - Anti-c-Myc (phospho S62) antibody [33A12E10] (AB78318)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-c-Myc (phospho S62) antibody [33A12E10] (AB78318)

Proximity Ligation Analysis with anti-cMyc pS62 and CIP2A antibodies, association of cMyc pS62 with CIP2A (red) in nuclei (DAPI, blue) of HeLa cells by ICC/IF.

Flow Cytometry (Intracellular) - Anti-c-Myc (phospho S62) antibody [33A12E10] (AB78318)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-c-Myc (phospho S62) antibody [33A12E10] (AB78318)

Overlay histogram showing HL60 cells stained with ab78318 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab78318, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was a Goat Anti-Mouse DyLight® 488 (IgG; H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2b [PLPV219] (ab91366, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HL60 cells fixed in 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.

Western blot - Anti-c-Myc (phospho S62) antibody [33A12E10] (AB78318)
  • WB

Unknown

Western blot - Anti-c-Myc (phospho S62) antibody [33A12E10] (AB78318)

All lanes:

Western blot - Anti-c-Myc (phospho S62) antibody [33A12E10] (ab78318) at 1 µg/mL

Lane 1:

Crude cell extracts of AGS (gastric adenocarcinoma) cells with Scr (scrambled) siRNA introduced into the cells as a negative control

Lane 2:

Crude cell extracts of AGS (gastric adenocarcinoma) cells transfected with a negative control siRNA

Lane 3:

Crude cell extracts of AGS (gastric adenocarcinoma) cells transfected with siRNA for c-Myc

Predicted band size: 48 kDa

Observed band size: 60 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

33A12E10

Isotype

IgG2b

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

IHC-P, ICC/IF, Flow Cyt (Intra), WB

applications

Immunogen

Synthetic Peptide within Human MYC phospho S62. The exact immunogen used to generate this antibody is proprietary information.

P01106

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "5 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "0.5-1 µg/mL", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1 µg for 10^6 Cells", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg2b-kappa-monoclonal-7e10g10-isotype-control-ab170192'>ab170192</a> - Mouse monoclonal IgG2b, is suitable for use as an isotype control with this antibody.</p>" }, "Mouse": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "predicted", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Rat": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "predicted", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Ion exchange chromatography
Storage buffer
pH: 6 - 8.5 Constituents: PBS, 50% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

C-Myc also known simply as Myc or MYC protein is a transcription factor with significant roles in cellular processes. Its estimated molecular weight is approximately 62 kDa. This protein is expressed in various tissues and cell types including common use in HEK (human embryonic kidney) cells for research. c-Myc functions by regulating transcription of genes involved in cell cycle progression apoptosis and cellular transformation.
Biological function summary

C-Myc is involved in regulating cell growth and proliferation. It forms part of the Myc/Max complex which binds to DNA to regulate gene expression. This activity affects cellular metabolism ribosome biogenesis and cell cycle entry emphasizing its regulation of cellular energy and stress response. Its expression levels critically govern normal cellular functions and homeostasis.

Pathways

C-Myc plays an important role in the cell cycle pathway and apoptosis regulation. Specifically c-Myc is associated with the Wnt signaling pathway which influences cellular proliferation and differentiation. It also interacts with other proteins like Cyclin D1 influencing cell cycle control. These interactions ensure c-Myc's involvement in regulating key processes related to cell proliferation and stability.

C-Myc is tightly linked to cancer such as Burkitt's lymphoma and colon cancer. In these conditions c-Myc overexpression contributes to uncontrolled cell proliferation. Additionally c-Myc is associated with other oncogenic proteins like BCL2 in tumorigenesis highlighting its pivotal role in cancer development and progression. Understanding c-Myc's involvement in these diseases aids in the development of targeted therapeutic strategies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcription factor that binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3' (PubMed : 24940000, PubMed : 25956029). Activates the transcription of growth-related genes (PubMed : 24940000, PubMed : 25956029). Binds to the VEGFA promoter, promoting VEGFA production and subsequent sprouting angiogenesis (PubMed : 24940000, PubMed : 25956029). Regulator of somatic reprogramming, controls self-renewal of embryonic stem cells (By similarity). Functions with TAF6L to activate target gene expression through RNA polymerase II pause release (By similarity). Positively regulates transcription of HNRNPA1, HNRNPA2 and PTBP1 which in turn regulate splicing of pyruvate kinase PKM by binding repressively to sequences flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform (PubMed : 20010808).
See full target information MYC phospho S62

Publications (34)

Recent publications for all applications. Explore the full list and refine your search

Cell communication and signaling : CCS 23:390 PubMed40898325

2025

ATE1 promotes breast cancer progression via arginylation-dependent regulation of MAPK-MYC signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Laxman Nawale,Shinyeong Ju,Jung Gi Kim,Nak Kyun Soung,Bo Yeon Kim,Cheolju Lee,Hyunjoo Cha-Molstad

CytoJournal 21:49 PubMed39737117

2024

Immunoglobulin superfamily member 1 upregulates myc proto-oncogene to accelerate invasion and metastasis of endometrial cancer: Molecular mechanisms and therapeutic prospects.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Wei,Jinxiang Jiang,Shuhong Zhang,Shuai Dong

Pharmaceutics 15: PubMed38139993

2023

Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor Microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Vidhi M Shah,Syed Rizvi,Alexander Smith,Motoyuki Tsuda,Madeline Krieger,Carl Pelz,Kevin MacPherson,Jenny Eng,Koei Chin,Michael W Munks,Colin J Daniel,Adel Al-Fatease,Galip Gürkan Yardimci,Ellen M Langer,Jonathan R Brody,Brett C Sheppard,Adam Wg Alani,Rosalie C Sears

Clinical and translational medicine 13:e1153 PubMed36639831

2023

Small molecule Z363 co-regulates TAF10 and MYC via the E3 ligase TRIP12 to suppress tumour growth.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Xiong,Lulu Wang,Shiyao Xu,Beibei Fu,Yuchen Che,Mohamed Y Zaky,Rong Tian,Rui Yao,Dong Guo,Zhou Sha,Feng Lin,Xiaoyuan Lin,Haibo Wu

Molecular oncology 17:1007-1023 PubMed36461911

2022

PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers.

Applications

Unspecified application

Species

Unspecified reactive species

Anna Aakula,Aleksi Isomursu,Christian Rupp,Andrew Erickson,Nikhil Gupta,Otto Kauko,Pragya Shah,Artur Padzik,Yuba Raj Pokharel,Amanpreet Kaur,Song-Ping Li,Lloyd Trotman,Pekka Taimen,Antti Rannikko,Jan Lammerding,Ilkka Paatero,Tuomas Mirtti,Johanna Ivaska,Jukka Westermarck

Molecular cancer research : MCR 20:1151-1165 PubMed35380701

2022

T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62.

Applications

Unspecified application

Species

Unspecified reactive species

Colin J Daniel,Carl Pelz,Xiaoyan Wang,Michael W Munks,Aaron Ko,Dhaarini Murugan,Sarah A Byers,Eleonora Juarez,Karyn L Taylor,Guang Fan,Lisa M Coussens,Jason M Link,Rosalie C Sears

Nucleic acids research 50:3505-3522 PubMed35244724

2022

The MYC oncoprotein directly interacts with its chromatin cofactor PNUTS to recruit PP1 phosphatase.

Applications

Unspecified application

Species

Unspecified reactive species

Yong Wei,Cornelia Redel,Alexandra Ahlner,Alexander Lemak,Isak Johansson-Åkhe,Scott Houliston,Tristan M G Kenney,Aaliya Tamachi,Vivian Morad,Shili Duan,David W Andrews,Björn Wallner,Maria Sunnerhagen,Cheryl H Arrowsmith,Linda Z Penn

Cell chemical biology 29:358-372.e5 PubMed34525344

2021

Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ratika Kunder,Michelle Velyunskiy,Sara F Dunne,Byoung-Kyu Cho,Deepak Kanojia,Lauren Begg,Adrienne M Orriols,Erica Fleming-Trujillo,Pranathi Vadlamani,Alesia Vialichka,Rosemary Bolin,Jessica N Perrino,Diane Roth,Matthew R Clutter,Nicolette A Zielinski-Mozny,Young Ah Goo,Massimo Cristofanilli,Marc L Mendillo,Athanassios Vassilopoulos,Dai Horiuchi

Molecular cancer therapeutics 20:676-690 PubMed33568357

2021

PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition-Dependent GSK-3β-Mediated c-Myc and Pim-1 Proteasomal Degradation.

Applications

Unspecified application

Species

Unspecified reactive species

Mario Scarpa,Prerna Singh,Christopher M Bailey,Jonelle K Lee,Shivani Kapoor,Rena G Lapidus,Sandrine Niyongere,Jaya Sangodkar,Yin Wang,Danilo Perrotti,Goutham Narla,Maria R Baer

Phytomedicine : international journal of phytotherapy and phytopharmacology 80:153383 PubMed33091855

2020

Antileukemic effect of caffeic acid 3,4-dihydroxyphenetyl ester. Evidences for its mechanisms of action.

Applications

Unspecified application

Species

Unspecified reactive species

Mingmin Tang,Xin Xie,Muran Shi,Wenxiu Xin,Guowan Zheng,Yanhua Zhang,Zhizhen Zhang,Xiaoyuan Lian
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com